Genetic Modulation of Homocysteinemia (original) (raw)

Semin Thromb Hemost 2000; Volume 26(Number 03): 255-262
DOI: 10.1055/s-2000-8470

Departments of Human Genetics, Pediatrics, and Biology, McGill University, Montreal Children's Hospital, Montreal, Canada

Further Information

Publication History

Publication Date:
31 December 2000 (online)

ABSTRACT

With the identification of hyperhomocysteinemia as a risk factor for cardiovascular disease, an understanding of the genetic determinants of plasma homocysteine is important for prevention and treatment. It has been known for some time that homocystinuria, a rare inborn error of metabolism, can be due to genetic mutations that severely disrupt homocysteine metabolism. A more recent development is the finding that milder, but more common, genetic mutations in the same enzymes might also contribute to an elevation in plasma homocysteine. The best example of this concept is a missense mutation (alanine to valine) at base pair (bp) 677 of methylenetetrahydrofolate reductase (MTHFR), the enzyme that provides the folate derivative for conversion of homocysteine to methionine. This mutation results in mild hyperhomocysteinemia, primarily when folate levels are low, providing a rationale (folate supplementation) for overcoming the genetic deficiency.

Additional genetic variants in MTHFR and in other enzymes of homocysteine metabolism are being identified as the cDNAs/genes become isolated. These variants include a glutamate to alanine mutation (bp 1298) in MTHFR, an aspartate to glycine mutation (bp 2756) in methionine synthase, and an isoleucine to methionine mutation (bp 66) in methionine synthase reductase. These variants have been identified relatively recently; therefore additional investigations are required to determine their clinical significance with respect to mild hyperhomocysteinemia and vascular disease.

KEYWORD

Homocysteine - folate - genetics - methylenetetrahydrofolate reductase - methionine synthase

REFERENCES

1 Rozen R. Methylenetetrahydrofolate reductase in vascular disease, neural tube defects and colon cancer. in: Mato JM, Caballero A, eds. Proceedings of the 4th Workshop on Methionine Metabolism Madrid, Spain: Consejo Superior de Investigaciones Cientificas Publishers, 1998: 51-61
2 Leclerc D, Wilson A, Dumas R. Cloning and mapping of a cDNA for methionine synthase reductase, a flavoprotein defective in patients with homocystinuria. Proc Natl Acad Sci U S A . 1998; 95 3059-3064
3 Garrow T A, Millian N S, Park E I. The influence of nutrition on rat liver betaine-homocysteine methyltransferase expression and preliminary characterization of recombinant human BHMT as a zinc metalloenzyme. in: Mato JM, Caballero A, eds. Proceedings of the 4th Workshop on Methionine Metabolism Madrid, Spain: Consejo Superior de Investigaciones Cientificas Publishers, 1998 : 63-76
4 Kraus J P, Miroslav J, Viktor K. Cystathionine β-synthase mutations in homocystinuria. Hum Mutat . 1999; 13 362-375
5 Leclerc D, Campeau E, Goyette P. Human methionine synthase:cDNA cloning, chromosomal localization, and identification of mutations in patients of the _cbl_G complementation group of folate/cobalamin disorders. Hum Mol Genet . 1996; 5 1867-1874
6 Li Y N, Gulati S, Baker P J. Cloning, mapping and RNA analysis of the human methionine synthase gene. Hum Mol Genet . 1996; 5 1851-1858
7 Chen L H, Liu M-L, Hwang H-Y. Human methionine synthase. cDNA cloning, gene localization and expression. J Biol Chem . 1997; 272 3628-3634
8 Gulati S, Baker P, Yunan L N. Defects in human methionine synthase in cblG patients. Hum Mol Genet . 1996; 5 1859-1865
9 Wilson A, Leclerc D, Saberi F. Functionally null mutations in patients with the cblG-variant form of methionine synthase deficiency. Am J Hum Genet . 1998; 63 409-414
10 Wilson A, Leclerc D, Rosenblatt D S, Gravel R A. Molecular basis for methionine synthase reductase deficiency in patients belonging to the cblE complementation group of disorders in folate/cobalamin metabolism. Hum Mol Genet . 1999; 8 2009-2016
11 Sibani S, Christensen B, O'Ferrell E. Characterization of six novel mutations in the methylenetetrahydrofolate reductase (MTHFR) gene in patients with homocystinuria. Human Mutation . 2000; 15 280-287
12 Goyette P, Frosst P, Rosenblatt D S, Rozen, R. Seven novel mutations in the methylenetetrahydrofolate reductase gene and genotype/phenotype correlations in severe MTHFR deficiency. Am J Hum Genet . 1995; 56 1052-1059
13 Goyette P, Christensen B, Rosenblatt D S, Rozen R. Severe and mild mutations in cis for the methylenetetrahydrofolate reductase (MTHFR) gene, and description of 5 novel mutations in MTHFR. Am J Hum Genet . 1996; 59 1268-1275
14 Kluijtmans L A, den Heijer J, Reitsma P H. Thermolabile methylenetetrahydrofolate reductase and factor V Leiden in the risk of deep-vein thrombosis. Thromb Haemost . 1998; 79 254-258
15 Garrow T A. Purification, kinetic properties, and cDNA cloning of mammalian betaine-homocysteine methyltransferase. J Biol Chem . 1996; 271 22831-22838
16 Rosenblatt D S. Inherited disorders of folate transport and metabolism. in: Scriver CR, Beaudet AL, Sly WS, Valle D, eds. The Metabolic and Molecular Bases of Inherited Disease, 7th ed New York: McGraw-Hill, 1995: 3111-3128
17 Frosst P, Blom H J, Milos R. A candidate genetic risk factor for vascular disease: A common mutation in methylenetetrahydrofolate reductase. Nat Genet . 1995; 10 111-113
18 Kang S-S, Wong P WK, Susmano A. Thermolabile methylenetetrahydrofolate reductase: An inherited risk factor for coronary disease. Am J Hum Genet . 1991; 48 536-545
19 Engbersen A MT, Franken D G, Boers G HJ. Thermolabile 5,10-methylenetetrahydrofolate reductase as a cause of mild hyperhomocysteinemia. Am J Hum Genet . 1995; 56 142-150
20 Jacques P F, Bostom A G, Williams R R. Relation between folate status, a common mutation in methylenetetrahydrofolate reductase, and plasma homocysteine concentrations. Circulation . 1996; 93 7-9
21 Ma J, Stampfer M J, Giovannucci E. Methylenetetrahydrofolate reductase polymorphism, reduced risk of colorectal cancer and dietary interactions. Cancer Res . 1997; 57 1098-1102
22 Chen J, Giovannucci E, Kelsey K. A methylenetetrahydrofolate reductase polymorphism and the risk of colorectal cancer. Cancer Res . 1996; 56 4862-4864
23 Morita H, Taguchi J-I, Kurihara H. Genetic polymorphism of 5,10-methylenetetrahydrofolate reductase (MTHFR) as a risk factor for coronary artery disease. Circulation . 1997; 95 2032-2036
24 Park K S, Podskarbi T, Yoo E A, Shin Y S. The C677T mutation in the methylenetetrahydrofolate reductase gene in Koreans. Korean J Genet . 1998; 20 23-28
25 Cattaneo M, Tsai M Y, Bucciarelli P. A common mutation in the methylenetetrahydrofolate reductase gene (C677T) increases the risk for deep-vein thrombosis in patients with mutant factor V (factor V :Q506). Arterioscler Thromb Vasc Biol . 1997; 17 1662-1666
26 Margaglione M, D'Andrea G, d'Addedda M. The methylenetetrahydrofolate reductase TT677 genotype is associated with venous thrombosis independently of the coexistence of the FV Leiden and the prothrombin A20210 mutation. Thromb Haemost . 1998; 79 907-911
27 Shaw G M, Rozen R, Finnell R H, Wasserman C R, Lammer E J. Maternal vitamin use, genetic variation of infant methylenetetrahydrofolate reductase and risk for spina bifida. Am J Epidemiol . 1998; 148 30-37
28 Vanegas O C, Giusti B, Fernandez C MR, Abbate R, Pepe G. Frequency of Factor V (FV) Leiden and C677T methylenetetrahydrofolate reductase (MTHFR) mutations in Colombians. Thromb Haemost . 1998; 79 883-884
29 Harmon D L, Woodside J V, Yarnell J WG. The common ``thermolabile'' variant of methylene tetrahydrofolate reductase is a major determinant of mild hyperhomocysteinaemia. QJM . 1996; 89 571-577
30 Guttormsen A B, Ueland P M, Nesthus I. Determinants and vitamin responsiveness of intermediate hyperhomocysteinemia (>40 μmol/liter). J Clin Invest . 1996; 98 2174-2183
31 Malinow M R, Nieto F J, Kruger W D. The effects of folic acid supplementation on plasma total homocysteine are modulated by multivitamin use and methylenetetrahydrofolate reductase genotypes. Arterioscler Thromb Vasc Biol . 1997; 17 1157-1162
32 Guenther B D, Sheppard C A, Tran P. The structure and properties of methylenetetrahydrofolate reductase from Escherichia coli: A model for the role of folate in ameliorating hyperhomocysteinemia in humans. Nat Struct Biol . 1999; 6 359-365
33 Balasa V V, Gruppo R A, Glueck, C J. The relationship of mutations in the MTHFR, prothrombin, and PAI-1 genes to plasma levels of homocysteine, prothrombin, and PAI-1 in children and adults. Thromb Haemost . 1999; 81 739-744
34 Weisberg I, Tran P, Christensen B, Sibani S, Rozen R. A second genetic polymorphism in methylenetetrahydofolate reductase (MTHFR) associated with decreased enzyme activity. Mol Genet Metab . 1998; 64 169-172
35 van der Put N MY, Gabreels F, Stevens E MB. A second common mutation in the methylenetetrahydrofolate reductase gene: An additional risk factor for neural-tube defects?. Am J Hum Genet . 1998; 62 1044-1051
36 Morita H, Kurihara H, Sugiyama T. Polymorphism of the methionine synthase gene-association with homocysteine metabolism and late-onset vascular diseases in the Japanese population. Arterioscler Thromb Vasc Biol . 1999; 19 298-302
37 Tsai M Y, Welge B G, Hanson N Q. Genetic causes of mild hyperhomocysteinemia in patients with premature occlusive coronary artery diseases. Atherosclerosis . 1999; 143 163-170
38 Wilson A, Platt R, Wu Q. A common variant in methionine synthase reductase combined with low cobalamin (vitamin B12) increases risk for spina bifida. Mol Genet Metab . 1999; 67 317-323
39 Kluijtmans L AJ, van den Heuvel L P, Boers G HJ. Molecular genetic analysis in mild hyperhomocysteinemia: A common mutation in the methylenetetrahydrofolate reductase gene is a genetic risk factor for cardiovascular disease. Am J Hum Genet . 1996; 58 35-41
40 Gallagher P, Meleady R, Shields D. Homocysteine and risk of coronary heart disease: Evidence for a common gene mutation. Circulation . 1996; 94 2154-2158
41 Arruda V R, von Zuben P M, Chiaparini L C, Annichino-Bizzacchi J M, Costa F F. The mutation Ala677 → Val in the methylene - tetrahydrofolate reductase gene : A risk factor for arterial disease and venous thrombosis. Thromb Haemost . 1997; 77 818-821
42 Morita H, Kurihara H, Tsubaki S. Methylenetetrahydrofolate reductase gene polymorphism and ischemic stroke in Japanese. Arterioscler Thromb Vasc Biol . 1998; 18 1465-1469
43 Ma J, Stampfer M J, Hennekens C H. Methylenetetrahydrofolate reductase polymorphism, plasma folate, homocysteine, and risk of myocardial infarction in U.S physicians. Circulation . 1996; 94 2410-2416
44 Wilcken D EL, Wang X L, Sim A S, McCredie R M. Distribution in healthy and coronary populations of the methylenetetrahydrofolate reductase (MTHFR) C677T mutation. Arterioscler Thromb Vasc Biol . 1996; 16 878-882
45 Markus H S, Ali N, Swaminathan R. A common polymorphism in the methylenetetrahydrofolate reductase gene, homocysteine, and ischemic cerebrovascular disease. Stroke . 1997; 28 1739-1743
46 Fletcher O, Kessling A M. MTHFR association with arteriosclerotic vascular disease?. Hum Genet . 1998; 103 11-21
47 Stevenson R E, Schwartz C E, Du Y Z, Adams M J. Differences in methylenetetrahydrofolate reductase genotype frequencies, between whites and blacks. Am J Hum Genet . 1997; 60 230-233
48 Inbal A, Freimark D, Modan B. Synergistic effects of prothrombotic polymorphisms and atherogenic factors on the risk of myocardial infarction in young males. Blood . 1999; 93 2186-2190
49 Arai K, Yamasaki Y, Kajimoto Y. Association of methylenetetrahydrofolate reductase gene polymorphism with carotid arterial wall thickening and myocardial infarction risk in NIDDM. Diabetes . 1997; 46 2102-2104
50 Nelen W LDM, Steegers E AP, Eskes T KAB, Blom H J. Genetic risk factor for unexplained recurrent early pregnancy loss. Lancet . 1997; 350 861
51 Kupferminc M J, Eldor A, Steinman N. Increased frequency of genetic thrombophilia in women with complications of pregnancy. N Engl J Med . 1999; 340 9-13
52 Loewenstein A, Winder A, Goldstein M, Lazar M, Eldor A. Bilateral retinal vein occlusion associated with 5,10-methylenetetrahydrofolate reductase mutation. Am J Ophthalmol . 1997; 124 840-841
53 Neugebauer S, Baba T, Kurokawa K, Watanabe T. Defective homocysteine metabolism as a risk factor for diabetic retinopathy. Lancet . 1997; 349 473-474
54 van der Put N MJ, Eskes T KAB, Blom H J. Is the common 677C → T mutation in the methylenetetrahydrofolate reductase gene a risk factor for neural tube defects?. <~>A meta-analysis. QJM . 1997; 90 111-115
55 Regland B, Germgard T, Gottfries C G, Grenfeldt B, Koch-Schmidt A C. Homozygous thermolabile methylenetetrahydrofolate reductase in schizophrenia-like psychosis. J Neural Transm . 1997; 104 931-941
56 Arinami T, Yamada N, Yamakawa-Kobayashi K, Hamaguchi H, Toru M. Methylenetetrahydrofolate reductase variant and schizophrenia/depression. Am J Med Genet . 1997; 74 526-528
57 Ma J, Stampfer M J, Christensen B. A polymorphism of the methionine synthase gene: Association with plasma folate, vitamin B12, homocysteine, and colorectal cancer risk. Cancer Epidemiol Biomarkers Prev . 1999; 8 825-829